Theseus Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Cash & Equivalents	285.47	355.24	507.84	651.37	833.6	Upgrade
Short-Term Investments	782.03	969.48	849.38	869.99	806.84	Upgrade
Trading Asset Securities	886.46	838.05	779.88	1,043	656.21	Upgrade
Cash & Short-Term Investments	1,954	2,163	2,137	2,564	2,297	Upgrade
Cash Growth	-9.65%	1.20%	-16.65%	11.64%	108.80%	Upgrade
Accounts Receivable	397.2	344.81	369.98	366.16	388.74	Upgrade
Other Receivables	204.69	147.81	273.53	196.88	239.6	Upgrade
Receivables	601.88	492.62	643.51	733.03	1,028	Upgrade
Inventory	4,030	3,943	3,689	3,112	3,002	Upgrade
Prepaid Expenses	56.75	43.34	52.42	38.37	33.41	Upgrade
Other Current Assets	691.16	323.56	169.28	511.21	503.25	Upgrade
Total Current Assets	7,333	6,965	6,692	6,959	6,864	Upgrade
Property, Plant & Equipment	11,818	11,989	11,777	11,416	10,849	Upgrade
Long-Term Investments	28.26	1.74	1.9	2.3	56.69	Upgrade
Other Intangible Assets	85.29	89.27	93.26	97.12	75.98	Upgrade
Other Long-Term Assets	2,397	1,634	1,338	811.1	730.88	Upgrade
Total Assets	21,662	20,679	19,902	19,285	18,577	Upgrade
Accounts Payable	2,448	2,355	2,494	1,774	1,940	Upgrade
Accrued Expenses	693.87	629.06	682.99	587.34	642.23	Upgrade
Short-Term Debt	3,517	2,701	2,395	1,742	1,332	Upgrade
Current Portion of Long-Term Debt	689.93	845	811.42	863.18	804.36	Upgrade
Current Portion of Leases	13.26	23.66	21.94	13.42	11.74	Upgrade
Current Income Taxes Payable	45.5	64.78	-	70.22	145.3	Upgrade
Current Unearned Revenue	260.57	273.91	345.02	433.99	362.68	Upgrade
Other Current Liabilities	1,308	1,345	1,040	1,218	1,312	Upgrade
Total Current Liabilities	8,976	8,236	7,790	6,702	6,551	Upgrade
Long-Term Debt	1,942	2,449	2,909	3,630	4,126	Upgrade
Long-Term Leases	110.71	56.99	77.42	33.75	47.17	Upgrade
Long-Term Unearned Revenue	279.05	162.96	135.77	83.63	54.62	Upgrade
Long-Term Deferred Tax Liabilities	982.22	859.39	640.75	582.92	280.99	Upgrade
Other Long-Term Liabilities	633.44	596.32	584.38	621.47	657.37	Upgrade
Total Liabilities	13,143	12,563	12,340	11,863	11,899	Upgrade
Common Stock	274.97	274.97	274.97	274.97	274.97	Upgrade
Additional Paid-In Capital	180.58	180.58	180.58	180.58	180.58	Upgrade
Retained Earnings	8,040	7,640	7,087	6,947	6,203	Upgrade
Comprehensive Income & Other	22.9	20.16	19.44	19.7	19.7	Upgrade
Shareholders' Equity	8,519	8,116	7,562	7,422	6,678	Upgrade
Total Liabilities & Equity	21,662	20,679	19,902	19,285	18,577	Upgrade
Total Debt	6,273	6,075	6,215	6,282	6,322	Upgrade
Net Cash (Debt)	-4,319	-3,912	-4,078	-3,718	-4,025	Upgrade
Net Cash Per Share	-157.08	-142.27	-148.29	-135.22	-146.39	Upgrade
Filing Date Shares Outstanding	27.5	27.5	27.5	27.5	26.69	Upgrade
Total Common Shares Outstanding	27.5	27.5	27.5	27.5	26.69	Upgrade
Working Capital	-1,643	-1,271	-1,099	256.91	312.65	Upgrade
Book Value Per Share	309.81	295.16	275.02	269.91	250.17	Upgrade
Tangible Book Value	8,434	8,027	7,469	7,325	6,602	Upgrade
Tangible Book Value Per Share	306.70	291.92	271.63	266.38	247.33	Upgrade
Land	765.85	765.85	765.85	765.85	764.67	Upgrade
Buildings	2,512	2,423	1,977	1,783	1,170	Upgrade
Machinery	12,946	12,358	12,158	11,463	9,882	Upgrade
Construction In Progress	54.43	431.7	171.17	102.42	1,123	Upgrade

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.